KINGDON CAPITAL MANAGEMENT, L.L.C. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 243 filers reported holding HAEMONETICS CORP in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
KINGDON CAPITAL MANAGEMENT, L.L.C. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$9,952,338
+140.5%
111,100
+122.2%
1.15%
+47.3%
Q1 2023$4,137,500
-33.5%
50,000
-47.6%
0.78%
-26.3%
Q2 2022$6,225,000
-65.0%
95,500
-71.5%
1.06%
-48.3%
Q4 2021$17,768,000
+25.9%
335,000
+67.5%
2.04%
+18.9%
Q3 2021$14,118,000200,0001.72%
Other shareholders
HAEMONETICS CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders